RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재후보

      베타-락탐 항생제 알레르기 및 교차반응 = Beta-Lactam Allergy and Cross-Reactivity

      한글로보기

      https://www.riss.kr/link?id=A100201481

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Penicillins and cephalosporins are commonly prescribed beta-lactam antibiotics that are able to induce severe and sometimes even life-threatening hypersensitivity reactions. These reactions can be broadly classified as immediate or non immediate/delayed depending on the onset of the reaction after the last drug administration. A definitive diagnosis of beta-lactam hypersensitivity is required to carry out the proper preventive measures. The diagnostic approach to beta-lactam allergy should be considered if the risk/possible benefit ratio is positive. In Korea, however, the diagnostic approach to beta-lactam allergy remains a major challenge. Major and minor determinants of penicillin for skin testing are unavailable, making skin testing appear to be less sensitive. Drug allergy work-ups that include standardized skin tests, reliable in vitro tests, and drug provocation tests are rarely carried out in clinical practice. However, screening patients without a prior history of beta-lactam allergy is routinely recommended. In this review, we discuss practical evaluation of beta-lactam allergy and cross-reactivity between penicillins and cephalosporins. (Korean J Med 2014,87:652-658)
      번역하기

      Penicillins and cephalosporins are commonly prescribed beta-lactam antibiotics that are able to induce severe and sometimes even life-threatening hypersensitivity reactions. These reactions can be broadly classified as immediate or non immediate/delay...

      Penicillins and cephalosporins are commonly prescribed beta-lactam antibiotics that are able to induce severe and sometimes even life-threatening hypersensitivity reactions. These reactions can be broadly classified as immediate or non immediate/delayed depending on the onset of the reaction after the last drug administration. A definitive diagnosis of beta-lactam hypersensitivity is required to carry out the proper preventive measures. The diagnostic approach to beta-lactam allergy should be considered if the risk/possible benefit ratio is positive. In Korea, however, the diagnostic approach to beta-lactam allergy remains a major challenge. Major and minor determinants of penicillin for skin testing are unavailable, making skin testing appear to be less sensitive. Drug allergy work-ups that include standardized skin tests, reliable in vitro tests, and drug provocation tests are rarely carried out in clinical practice. However, screening patients without a prior history of beta-lactam allergy is routinely recommended. In this review, we discuss practical evaluation of beta-lactam allergy and cross-reactivity between penicillins and cephalosporins. (Korean J Med 2014,87:652-658)

      더보기

      참고문헌 (Reference)

      1 Yoon SY, "Validation of the cephalosporin intradermal skin test for predicting immediate hypersensitivity:a prospective study with drug challenge" 68 : 938-944, 2013

      2 Blanca M, "Update on the evaluation of hypersensitivity reactions to betalactams" 64 : 183-193, 2009

      3 Campagna JD, "The use of cephalosporins in penicillin-allergic patients: a literature review" 42 : 612-620, 2012

      4 Lee CE, "The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance" 160 : 2819-2822, 2000

      5 Co Minh HB, "Systemic reactions during skin tests with beta-lactams: a risk factor analysis" 117 : 466-468, 2006

      6 Smith JW, "Studies on the epidemiology of adverse drug reactions. II. An evaluation of penicillin allergy" 274 : 998-1002, 1966

      7 Brockow K, "Skin test concentrations for systemically administered drugs - an ENDA/EAACI Drug Allergy Interest Group position paper" 68 : 702-712, 2013

      8 Padial A, "Non-immediate reactions to beta-lactams: diagnostic value of skin testing and drug provocation test" 38 : 822-828, 2008

      9 Demoly P, "International consensus on drug allergy" 69 : 420-437, 2014

      10 Antunez C, "Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins" 117 : 404-410, 2006

      1 Yoon SY, "Validation of the cephalosporin intradermal skin test for predicting immediate hypersensitivity:a prospective study with drug challenge" 68 : 938-944, 2013

      2 Blanca M, "Update on the evaluation of hypersensitivity reactions to betalactams" 64 : 183-193, 2009

      3 Campagna JD, "The use of cephalosporins in penicillin-allergic patients: a literature review" 42 : 612-620, 2012

      4 Lee CE, "The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance" 160 : 2819-2822, 2000

      5 Co Minh HB, "Systemic reactions during skin tests with beta-lactams: a risk factor analysis" 117 : 466-468, 2006

      6 Smith JW, "Studies on the epidemiology of adverse drug reactions. II. An evaluation of penicillin allergy" 274 : 998-1002, 1966

      7 Brockow K, "Skin test concentrations for systemically administered drugs - an ENDA/EAACI Drug Allergy Interest Group position paper" 68 : 702-712, 2013

      8 Padial A, "Non-immediate reactions to beta-lactams: diagnostic value of skin testing and drug provocation test" 38 : 822-828, 2008

      9 Demoly P, "International consensus on drug allergy" 69 : 420-437, 2014

      10 Antunez C, "Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins" 117 : 404-410, 2006

      11 Sanz ML, "Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate-type reactions to betalactam antibiotics" 32 : 277-286, 2002

      12 Romano A, "Evaluation of adverse cutaneous reactions to aminopenicillins with emphasis on those manifested by maculopapular rashes" 50 : 113-118, 1995

      13 Aberer W, "Drug provocation testing in the diagnosis of drug hypersensitivity reactions:general considerations" 58 : 854-863, 2003

      14 Demoly P, "Drug hypersensitivity:questionnaire. EAACI interest group on drug hypersensitivity" 54 : 999-1003, 1999

      15 Khan DA, "Drug allergy" 125 (125): S126-S137, 2010

      16 김민혜, "Diagnosis and Management of Immediate Hypersensitivity Reactions to Cephalosporins" 대한천식알레르기학회 6 (6): 485-495, 2014

      17 Romano A, "Diagnosing immediate reactions to cephalosporins" 35 : 1234-1242, 2005

      18 Romano A, "Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins" 141 : 16-22, 2004

      19 Gruchalla RS, "Clinical practice. Antibiotic allergy" 354 : 601-609, 2006

      20 Blanca M, "Clinical evaluation of pharmacia CAP system RAST FEIA amoxicilloyl and benzylpenicilloyl in patients with penicillin allergy" 56 : 862-870, 2001

      21 Romano A, "A case of IgE-mediated hypersensitivity to ceftriaxone" 104 : 1113-1114, 1999

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 계속평가 신청대상 (계속평가)
      2021-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      2018-12-01 평가 등재후보 탈락 (계속평가)
      2017-12-01 평가 등재후보로 하락 (계속평가) KCI등재후보
      2013-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-05-15 학술지명변경 외국어명 : Korean Journal of Medicine -> The Korean Journal of Medicine KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2003-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2002-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2000-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.1 0.1 0.1
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.11 0.1 0.259 0.02
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼